Kevin Waters - Mar 7, 2023 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
EVP, CFO
Signature
/s/ Jonathan Stone, Attorney-in-Fact for Kevin Waters
Stock symbol
PRCT
Transactions as of
Mar 7, 2023
Transactions value $
-$1,030,009
Form type
4
Date filed
3/9/2023, 04:24 PM
Previous filing
Feb 21, 2023
Next filing
Mar 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Sale -$244K -7.14K -8.22% $34.15 79.7K Mar 7, 2023 Direct F1
transaction PRCT Common Stock Sale -$758K -22K -27.65% $34.36 57.7K Mar 8, 2023 Direct F2
transaction PRCT Common Stock Sale -$28.8K -818 -1.42% $35.16 56.9K Mar 7, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.0000 to $34.7400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.0000 to $34.9925, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.0000 to $35.3600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.